WPI 2287 Pill - white capsule/oblong, 23mm
Pill with imprint WPI 2287 is White, Capsule/Oblong and has been identified as Propafenone Hydrochloride Extended-Release 425 mg. It is supplied by Actavis Pharma, Inc.
Propafenone is used in the treatment of Atrial Fibrillation; Wolff-Parkinson-White Syndrome; Atrial Flutter; Ventricular Tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 425 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 2287
Propafenone Hydrochloride Extended-Release
- Imprint
- WPI 2287
- Strength
- 425 mg
- Color
- White
- Size
- 23.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Group I antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00591-2287
- Inactive Ingredients
-
ferrosoferric oxide,
gelatin,
hypromelloses,
magnesium stearate,
potassium hydroxide,
propylene glycol,
shellac,
sodium lauryl sulfate,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
More about propafenone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (71)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: group I antiarrhythmics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.